<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39266971</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>12</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Prevalence and factors influencing long COVID among primary healthcare workers after epidemic control policy adjustment in Jiangsu, China.</ArticleTitle><Pagination><StartPage>964</StartPage><MedlinePgn>964</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">964</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-09764-5</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The persistent symptoms arising from COVID-19 infection pose a substantial threat to patients' health, carrying significant implications. Amidst the evolving COVID-19 control strategies in China, healthcare workers (HCWs) endure considerable stress. This study aims to evaluate the prevalence of long COVID infections and their influencing factors among primary HCWs after epidemic control policy adjustment in Jiangsu.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A self-designed questionnaire was administered through on-site surveys among primary HCWs in five counties and districts within Jiangsu Province from July 4 to July 20, 2023. Logistic regression analysis was employed to identify factors associated with long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of long COVID among primary HCWs stood at 12.61%, with a 95% confidence interval (CI) of 11.67-13.55%. Among those affected, the most common long COVID symptoms were hypomnesia (4.90%, 95%CI: 4.29-5.51%), sleep difficulties (2.73%, 95%CI: 2.27-3.19%), fatigue (2.35%, 95%CI: 1.92-2.78%), disturbances in the reproductive system (1.93%, 95%CI: 1.54-2.32%), hair loss (1.85%, 95%CI: 1.47-2.23%), and myalgia/arthralgia (1.51%, 95%CI: 1.16-1.86%). Multivariate logistic regression revealed that older age groups (30-45 years (adjusted odds ratio (aOR)&#x2009;=&#x2009;1.93, 95%CI: 1.44-2.58), 45-60 years (aOR&#x2009;=&#x2009;2.82, 95%CI: 2.07-3.84)), females (aOR&#x2009;=&#x2009;1.26, 95%CI: 1.03-1.55), and higher work stress (high stress (aOR&#x2009;=&#x2009;1.52, 95%CI: 1.24-1.86), extremely high stress (aOR&#x2009;=&#x2009;1.37, 95%CI: 1.03-1.82)) were more prone to long COVID. Conversely, individuals with educational attainment below the bachelor's degree (aOR&#x2009;=&#x2009;0.67, 95%CI: 0.55-0.82) and those who received four or more doses of the COVID-19 vaccine (aOR&#x2009;=&#x2009;0.55, 95%CI: 0.33-0.92) were at a reduced risk.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study investigates the prevalence of long COVID among primary HCWs and identifies key influencing factors. These findings are crucial for assisting in the early identification of COVID-19 patients at risk for long-term complications, developing targeted interventions aimed at optimizing healthcare resource allocation and enhancing the work conditions and quality of life of HCWs. To mitigate the prevalence of long COVID, healthcare providers and local authorities should implement effective measures, such as optimizing work-rest schedules and actively advocating for vaccination.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chen</LastName><ForeName>Hualing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Qian</LastName><ForeName>Yongkang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Beier</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Rongji</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Pengcheng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Mingwang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public health, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Haijian</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Ya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Zhengkai</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Biyun</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Statistics and Analysis Center, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yongjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. 371578804@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jinshui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China. 353112354@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Bingwei</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public health, Southeast University, Nanjing, China. drchenbw@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 2022A02</GrantID><Agency>Jiangsu Provincial Primary Health Development and General Practice Medical Education Research Center</Agency><Country/></Grant><Grant><GrantID>ZKX22019</GrantID><Agency>Health Commission of Nanjing</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="Y">Health Personnel</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">Healthcare workers</Keyword><Keyword MajorTopicYN="N">Influencing factors</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword></KeywordList><CoiStatement>The authors declared they had no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>13</Day><Hour>0</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39266971</ArticleId><ArticleId IdType="pmc">PMC11396294</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-09764-5</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-09764-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dhama K, Nainu F, Frediansyah A, et al. Global emerging Omicron variant of SARS-CoV-2: impacts, challenges and strategies. J Infect Public Health. 2023;16(1):4&#x2013;14. 10.1016/j.jiph.2022.11.024. 10.1016/j.jiph.2022.11.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.11.024</ArticleId><ArticleId IdType="pmc">PMC9675435</ArticleId><ArticleId IdType="pubmed">36446204</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard. Accessed October 9. 2023. https://covid19.who.int</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;7. 10.1016/S1473-3099(21)00703-9. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence (NICE). 2020. Accessed October 9, 2023. http://www.ncbi.nlm.nih.gov/books/NBK567261/</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK - Office for National Statistics. Accessed October 9. 2023. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023</Citation></Reference><Reference><Citation>The Lancet, Long COVID. 3 years in. Lancet. 2023;401(10379):795. 10.1016/S0140-6736(23)00493-2. 10.1016/S0140-6736(23)00493-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00493-2</ArticleId><ArticleId IdType="pmc">PMC9998094</ArticleId><ArticleId IdType="pubmed">36906338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L. Americans still facing COVID risk. Accessed October 9, 2023. https://www.chinadaily.com.cn/a/202205/12/WS627c7610a310fd2b29e5c3a5.html</Citation></Reference><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect. 2022;28(7):955&#x2013;72. 10.1016/j.cmi.2022.02.018. 10.1016/j.cmi.2022.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in Health Care workers. JAMA. 2022;328(7):676&#x2013;8. 10.1001/jama.2022.11691. 10.1001/jama.2022.11691</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Pal D, et al. Characteristics and predictors of long COVID among diagnosed cases of COVID-19. PLoS ONE. 2022;17(12):e0278825. 10.1371/journal.pone.0278825. 10.1371/journal.pone.0278825</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0278825</ArticleId><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, Lin K, Zhang H, et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg Microbes Infect. 2023;12(2):2220578. 10.1080/22221751.2023.2220578. 10.1080/22221751.2023.2220578</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2220578</ArticleId><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Rodr&#xed;guez E, P&#xe9;rula-de Torres L&#xc1;, Castro-Jim&#xe9;nez R, et al. Hospital admission and vaccination as predictive factors of long COVID-19 symptoms. Front Med (Lausanne). 2022;9:1016013. 10.3389/fmed.2022.1016013. 10.3389/fmed.2022.1016013</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1016013</ArticleId><ArticleId IdType="pmc">PMC9691755</ArticleId><ArticleId IdType="pubmed">36438042</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong MCS, Huang J, Wong YY, et al. Epidemiology, Symptomatology, and risk factors for long COVID symptoms: Population-Based, Multicenter Study. JMIR Public Health Surveill. 2023;9:e42315. 10.2196/42315. 10.2196/42315</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/42315</ArticleId><ArticleId IdType="pmc">PMC9994465</ArticleId><ArticleId IdType="pubmed">36645453</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun MC, Singh AK, Roy P, et al. Long COVID following Omicron wave in Eastern India-A retrospective cohort study. J Med Virol. 2023;95(1):e28214. 10.1002/jmv.28214. 10.1002/jmv.28214</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28214</ArticleId><ArticleId IdType="pmc">PMC9874641</ArticleId><ArticleId IdType="pubmed">36224705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. Associations of Depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of Post&#x2013;COVID-19 conditions. JAMA Psychiatry. 2022;79(11):1081&#x2013;91. 10.1001/jamapsychiatry.2022.2640. 10.1001/jamapsychiatry.2022.2640</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>The State Council Joint Prevention and Control Mechanism announces the. Notice on Further Optimizing the Implementation of COVID-19 Prevention and Control Measures. Accessed October 9, 2023. https://www.gov.cn/xinwen/2022-12/07/content_5730475.htm</Citation></Reference><Reference><Citation>Shukla AK, Atal S, Banerjee A, et al. An observational multi-centric COVID-19 sequelae study among health care workers. Lancet Reg Health Southeast Asia. 2022;10:100129. 10.1016/j.lansea.2022.100129. 10.1016/j.lansea.2022.100129</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lansea.2022.100129</ArticleId><ArticleId IdType="pmc">PMC9744681</ArticleId><ArticleId IdType="pubmed">36531928</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B, Ma R, Xu J, et al. Primary healthcare workers&#x2019; COVID-19 infection status following implementation of adjusted epidemic prevention and control strategies: a cross-sectional study in Jiangsu, China. Front Public Health. 2023;11. 10.3389/fpubh.2023.1297770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10770863</ArticleId><ArticleId IdType="pubmed">38186700</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. Major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46. 10.1038/s41579-022-00846-2. 10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144. 10.1038/s41598-021-95565-8. 10.1038/s41598-021-95565-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>da Costa E, Silva GR, Moura W&#xc9;A, Dos Santos KC, et al. Long-term symptoms after mild coronavirus disease in healthy Healthcare professionals: a 12-Month prospective cohort study. Int J Environ Res Public Health. 2023;20(2):1483. 10.3390/ijerph20021483. 10.3390/ijerph20021483</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021483</ArticleId><ArticleId IdType="pmc">PMC9865648</ArticleId><ArticleId IdType="pubmed">36674238</ArticleId></ArticleIdList></Reference><Reference><Citation>Notice on Issuing the Overall Plan for Implementing Class B Management of New Coronavirus Infections. Accessed October 11. 2023. https://www.gov.cn/xinwen/2022-12/27/content_5733739.htm</Citation></Reference><Reference><Citation>Pan Y, Wang L, Feng Z, et al. Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis. Lancet. 2023;401(10377):664&#x2013;72. 10.1016/S0140-6736(23)00129-0. 10.1016/S0140-6736(23)00129-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00129-0</ArticleId><ArticleId IdType="pmc">PMC9949854</ArticleId><ArticleId IdType="pubmed">36773619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou BF, Cooperative Meta-Analysis Group of the Working Group on Obesity in China. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults&#x2013;study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;15(1):83&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">12046553</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263&#x2013;4. 10.1016/S0140-6736(22)00941-2. 10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjei S, Hong K, Molinari NAM, et al. Mortality risk among patients hospitalized primarily for COVID-19 during the omicron and Delta variant pandemic periods - United States, April 2020-June 2022. MMWR Morb Mortal Wkly Rep. 2022;71(37):1182&#x2013;9. 10.15585/mmwr.mm7137a4. 10.15585/mmwr.mm7137a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7137a4</ArticleId><ArticleId IdType="pmc">PMC9484808</ArticleId><ArticleId IdType="pubmed">36107788</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J, Soto Conti CP, Gunier RB, et al. Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study. Lancet. 2023;401(10375):447&#x2013;57. 10.1016/S0140-6736(22)02467-9. 10.1016/S0140-6736(22)02467-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)02467-9</ArticleId><ArticleId IdType="pmc">PMC9910845</ArticleId><ArticleId IdType="pubmed">36669520</ArticleId></ArticleIdList></Reference><Reference><Citation>Prashar J. Long covid: conceptualizing the challenges for public health. J Public Health (Oxf). 2023;45(3):771&#x2013;9. 10.1093/pubmed/fdac153. 10.1093/pubmed/fdac153</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdac153</ArticleId><ArticleId IdType="pmc">PMC10470368</ArticleId><ArticleId IdType="pubmed">37132023</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Sanchis-Gomar F, Henry BM. COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med. 2023;133(4):16402. 10.20452/pamw.16402. 10.20452/pamw.16402</Citation><ArticleIdList><ArticleId IdType="doi">10.20452/pamw.16402</ArticleId><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Du M, Ma Y, Deng J, Liu M, Liu J. Comparison of long COVID-19 caused by different SARS-CoV-2 strains: a systematic review and Meta-analysis. Int J Environ Res Public Health. 2022;19(23):16010. 10.3390/ijerph192316010. 10.3390/ijerph192316010</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph192316010</ArticleId><ArticleId IdType="pmc">PMC9736973</ArticleId><ArticleId IdType="pubmed">36498103</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JPA, Zonta F, Levitt M. Estimates of COVID-19 deaths in Mainland China after abandoning zero COVID policy. medRxiv. Published online January 13, 2023:2022.12.29.22284048. 10.1101/2022.12.29.22284048</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10407651</ArticleId><ArticleId IdType="pubmed">36691703</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q, Sheikh A, Daines L, Vasileiou E. Symptoms and signs of long COVID: a rapid review and meta-analysis. J Glob Health. 2022;12:05014. 10.7189/jogh.12.05014. 10.7189/jogh.12.05014</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Marjenberg Z, Leng S, Tascini C, et al. Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis. Sci Rep. 2023;13:15332. 10.1038/s41598-023-42321-9. 10.1038/s41598-023-42321-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42321-9</ArticleId><ArticleId IdType="pmc">PMC10504382</ArticleId><ArticleId IdType="pubmed">37714919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv Published Online January. 2021;30. 2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022;434:120162. 10.1016/j.jns.2022.120162. 10.1016/j.jns.2022.120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Shetty A, Delanerolle G, et al. A systematic review and meta-analysis of long COVID symptoms. Syst Rev. 2023;12:88. 10.1186/s13643-023-02250-0. 10.1186/s13643-023-02250-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-023-02250-0</ArticleId><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Markiewicz-Gospodarek A, Wdowiak P, Czeczelewski M, et al. The impact of SARS-CoV-2 infection on fertility and female and male Reproductive systems. J Clin Med. 2021;10(19):4520. 10.3390/jcm10194520. 10.3390/jcm10194520</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194520</ArticleId><ArticleId IdType="pmc">PMC8509208</ArticleId><ArticleId IdType="pubmed">34640536</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;14. 10.1038/s41591-022-01909-w. 10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31. 10.1038/s41591-021-01292-y. 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75(10):e14357. 10.1111/ijcp.14357. 10.1111/ijcp.14357</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2022;28(4):611e. 9-611.e16.10.1016/j.cmi.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V, Hall Dykgraaf S, Kidd M, Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3(12):e849&#x2013;54. 10.1016/S2666-7568(22)00245-8. 10.1016/S2666-7568(22)00245-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId><ArticleId IdType="pubmed">36480981</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew NWS, Lee GKH, Tan BYQ, et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav Immun. 2020;88:559&#x2013;65. 10.1016/j.bbi.2020.04.049. 10.1016/j.bbi.2020.04.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.049</ArticleId><ArticleId IdType="pmc">PMC7172854</ArticleId><ArticleId IdType="pubmed">32330593</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, et al. Characteristics and impact of Long Covid: findings from an online survey. PLoS ONE. 2022;17(3):e0264331. 10.1371/journal.pone.0264331. 10.1371/journal.pone.0264331</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Strobl R, Apfelbacher C et al. Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS&#x2013;CoV&#x2013;2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort. Infection. Published online May 25, 2023:1&#x2013;16. doi:10/gr9xgm.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10212223</ArticleId><ArticleId IdType="pubmed">37231313</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>